Contract Notice Detail

Summary Information

Summary Information
 
31/2983/2023 
Medicamento Carboximaltose Férrica [50 MG/ML; 10 ML; SOL INJ; F/AMP] 
Tendering Phase
Awarded
31/2983/2023 - Medicamento Carboximaltose Férrica [50 MG/ML; 10 ML; SOL INJ; F/AMP] 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
C1224 - CARBOXIMALTOSE FÉRRICA [50 MG/ML; 10 ML; SOL INJ; F/AMP]1 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua Leão Penedo 8000-338 União das freguesias de Faro (Sé e São Pedro) Faro PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
6/16/2023 11:57 AM (UTC +1 hour)
 
2/19/2020 12:00 AM (UTC 0 hours)
 
6/19/2023 5:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
31000029832023.xlsx31000029832023.xlsxDownload
convite 258º.pdfconvite 258º.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
 
 
 1 
Questionário
 1.1  
 Lote 1Section for Lot - C1224 - CARBOXIMALTOSE FÉRRICA [50 MG/ML; 10 ML; SOL INJ; F/AMP]
 1.1.1   
Lote 1
Bill of Quantities *
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
     
Preço Total
0,000000
EUR
     
 
Cód. ArtigoReferência InternaDescriçãoQtUnidadePreço UnitárioPreço Total
     
C1224
CARBOXIMALTOSE FÉRRICA [50 MG/ML; 10 ML; SOL INJ; F/AMP]
1 200,000000
UN
 
516677586 | Vifor Pharma Portugal, S.A. | CPA:2020018/131/0088 | NºAIM:5242250;
  

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...